Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/20.500.12328/2463

Serotype distribution of remaining pneumococcal meningitis in the mature PCV10/13 period: findings from the PSERENADE project
Garcia Quesada, Maria; Yang, Yangyupei; Bennett, Julia C.; Hayford, Kyla; Zeger, Scott L.; Feikin, Daniel R.; Peterson, Meagan E.; Cohen, Adam L.; Almeida, Samanta C. G.; Ampofo, Krow; Ang, Michelle; Bar-Zeev, Naor; Bruce, Michael G.; Camilli, Romina; Chanto Chacón, Grettel; Ciruela, Pilar; Cohen, Cheryl; Corcoran, Mary; Dagan, Ron; De Wals, Philippe; Desmet, Stefanie; Diawara, Idrissa; Gierke, Ryan; Guevara, Marcela; Hammitt, Laura L.; Hilty, Markus; Ho, Pak-Leung; Jayasinghe, Sanjay; Kleynhans, Jackie; Kristinsson, Karl G.; Ladhani, Shamez N.; McGeer, Allison; Mwenda, Jason M.; Nuort, J. Pekka; Oishi, Kazunori; Ricketson, Leah J.; Sanz, Juan Carlos; Savrasova, Larisa; Setchanova, Lena Petrova; Smith, Andrew; Valentiner-Branth, Palle; Valenzuela, Maria Teresa; Van der Linden, Mark; Van Sorge, Nina M.; Varon, Emmanuelle; Winje, Brita A.; Yildirim, Inci; Zintgraff, Jonathan; Knoll, Maria Deloria; PSERENADE Team
Muñoz-Almagro, Carmen
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project described the serotype distribution of remaining pneumococcal meningitis in countries using PCV10/13 for least 5–7 years with primary series uptake above 70%. The distribution was estimated using a multinomial Dirichlet regression model, stratified by PCV product and age. In PCV10-using sites (N = 8; cases = 1141), PCV10 types caused 5% of cases <5 years of age and 15% among ≥5 years; the top serotypes were 19A, 6C, and 3, together causing 42% of cases <5 years and 37% ≥5 years. In PCV13-using sites (N = 32; cases = 4503), PCV13 types caused 14% in <5 and 26% in ≥5 years; 4% and 13%, respectively, were serotype 3. Among the top serotypes are five (15BC, 8, 12F, 10A, and 22F) included in higher-valency PCVs under evaluation. Other top serotypes (24F, 23B, and 23A) are not in any known investigational product. In countries with mature vaccination programs, the proportion of pneumococcal meningitis caused by vaccine-in-use serotypes is lower (≤26% across all ages) than pre-PCV (≥70% in children). Higher-valency PCVs under evaluation target over half of remaining pneumococcal meningitis cases, but questions remain regarding generalizability to the African meningitis belt where additional data are needed.
-Meningitis
-Vacunació dels infants
-Pneumococs
-Meningitis
-Vacunación infantil
-Streptococcus pneumoniae
-Meningitis
-Vaccination of infants
-Pneumococcus
-61
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
https://creativecommons.org/licenses/by/4.0/
Artículo
Artículo - Versión publicada
MDPI
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Bennett, Julia C.; Hetrich, Marissa K.; Garcia Quesada, Maria; Sinkevitch, Jenna N.; Deloria Knoll, Maria; Feikin, Daniel R.; Zeger, Scott L.; Kagucia, Eunice W.; Cohen, Adam L.; Ampofo, Krow; Brandileone, Maria-Cristina; Bruden, Dana; Camilli, Romina; Castilla, Jesús; Chan, Guanhao; Cook, Heather; Cornick, Jennifer E.; Dagan, Ron; Dalby, Tine; Danis, Kostas; De Miguel, Sara; De Wals, Philippe; Desmet, Stefanie; Georgakopoulou, Theano; Gilkison, Charlotte; Grgic-Vitek, Marta; Hammitt, Laura L.; Hilty, Markus; Ho, Pak-Leung; Jayasinghe, Sanjay; Kellner, James D.; Kleynhans, Jackie; Knol, Mirjam J.; Kozakova, Jana; Kristinsson, Karl G.; Ladhani, Shamez N.; MacDonald, Laura; Mackenzie, Grant A.; Mad’arová, Lucia; McGeer, Allison; Mereckiene, Jolita; Morfeldt, Eva; Mungun, Tuya; Muñoz-Almagro, Carmen; Nuort, J. Pekka; Paragi, Metka; Pilishvili, Tamara; Puentes, Rodrigo; Saha, Samir K.; Sahu Khan, Aalisha; Savrasova, Larisa; Scott, J. Anthony; Skoczynska, Anna; Suga, Shigeru; Van Der Linden, Mark; Verani, Jennifer R.; Von Gottberg, Anne; Winje, Brita A.; Yildirim, Inci; Zerouali, Khalid; Hayford, Kyla; PSERENADE Team
Hanquet, Germaine; Krizova, Pavla; Valentiner-Branth, Palle; Ladhani, Shamez N.; Nuorti, J. Pekka; Lepoutre, Agnes; Mereckiene, Jolita; Knol, Mirjam; Winje, Brita A.; Ciruela, Pilar; Ordobas, Maria; Guevara, Marcela; McDonald, Eisin; Morfeldt, Eva; Kozakova, Jana; Slotved, Hans-Christian; Fry, Norman K.; Rinta-Kokko, Hanna; Varon, Emmanuelle; Corcoran, Mary; Van der Ende, Arie; Vestrheim, Didrik F.; Muñoz-Almagro, Carmen; Latasa, Pello; Castilla, Jesús; Smith, Andrew; Henriques-Normark, Birgitta; Whittaker, Robert; Pastore Celentano, Lucia; Savulescu, Camelia; SpIDnet/I-MOVE+ Pneumo Group